Suppr超能文献

《德国法定医疗保险结构改革法九个月——影响与展望》

[Nine months German Statutory Health Insurance Structural Reform Law--effects and perspectives].

作者信息

Engel H

机构信息

AOK-Landesverband Bayern.

出版信息

Gesundheitswesen. 1994 Feb;56(2):76-9.

PMID:8148595
Abstract

In 1992 the German Statutory Health Insurance body was in the red by about 9,000 million DM and had the highest membership fees ever since it was created. Costing analysis revealed the following reasons for this enormous deficit: too expensive hospital financing a continually growing number of doctors and dental surgeons unrational drug prescription and supply. Of course, medical progress and demographic development are very significant costing factors. When assessing the impact of the Structural Reform Legislation we must differentiate between purely cost-reducing measures and structural changes. Cutting down the budgets in essential areas of compensation payment and slashing doctor's fees are like putting your foot down on the brake pedal. The statutory health insurance data for the first two quarters showed: doctors +3.4%, dental surgeons -4.3%. Limiting the budget for drugs to about 24,000 million DM and for remedial items to about 4,000 million DM with a possible collective slashing of the fees paid to doctors if these budgets were exceeded, proved to be an effective cost-reducing measure. In the case of drugs costs went down by 20.1% compared with the previous year (1992) due to an halt in prices charged by the drug industry and greater financial participation on the part of the patients. Prescriptions were reduced to a comparatively slight extent (1-2%), but the mode of prescription was much more economical.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1992年,德国法定医疗保险机构出现了约90亿德国马克的赤字,且自成立以来会员费达到了最高水平。成本分析揭示了造成这一巨额赤字的以下原因:医院费用过高、医生和牙医数量持续增加、药品处方和供应不合理。当然,医学进步和人口发展是非常重要的成本因素。在评估结构改革立法的影响时,我们必须区分纯粹的成本削减措施和结构变革。削减薪酬支付关键领域的预算以及大幅降低医生费用,就如同踩下刹车踏板。法定医疗保险前两个季度的数据显示:医生数量增加了3.4%,牙医数量减少了4.3%。将药品预算限制在约240亿德国马克,将治疗项目预算限制在约40亿德国马克,如果超出这些预算,可能会集体大幅削减支付给医生的费用,这被证明是一项有效的成本削减措施。就药品而言,由于制药行业价格停滞以及患者更多的财务参与,与上一年(1992年)相比,成本下降了20.1%。处方数量减少幅度相对较小(1%-2%),但处方方式更加经济。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验